GlassScriptPhysician profile
Christine W Ashour
NPI 1972866259
$1,041.85
in general payments reported to CMS, 2019-2025
18 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.15 · 2022: $16.53 · 2023: $40.55 · 2024: $486 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $151.99 | 2022-2025 | Mounjaro, Zepbound |
| Acadia Pharmaceuticals INC | $124.99 | 2024 | Nuplazid |
| Argenx US, INC. | $119.11 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Novo Nordisk INC | $96.58 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $91.73 | 2024-2025 | Shingrix, Arexvy, Bexsero |
| Inspire Medical Systems, INC. | $76.00 | 2024-2025 | Inspire |
| Irhythm Technologies, INC. | $54.38 | 2024 | Zio Monitor, Zio Xt Patch |
| Corcept Therapeutics | $45.45 | 2024-2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $43.03 | 2024-2025 | Hyqvia |
| Ucb, INC. | $37.13 | 2025 | Zilbrysq |
| Globus Medical, INC. | $32.95 | 2025 | Senza |
| Novartis Pharmaceuticals Corporation | $31.98 | 2025 | |
| Abbvie INC. | $28.95 | 2025 | |
| Csl Behring | $28.61 | 2025 | Hizentra |
| Calliditas Therapeutics US INC. | $26.89 | 2025 | Tarpeyo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.61 | 2025 | |
| Almatica Pharma LLC | $18.32 | 2025 | Teriparatide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Ashour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.